Literature DB >> 22574884

Genetic polymorphisms of antioxidant enzymes as risk factors for oxidative stress-associated complications in preterm infants.

Betti Giusti1, Anna Vestrini, Chiara Poggi, Alberto Magi, Elisabetta Pasquini, Rosanna Abbate, Carlo Dani.   

Abstract

We aimed to identify specific polymorphisms of genes encoding for superoxide dismutase (SOD) 1 (cytoplasmic Cu/ZnSOD), SOD2 (mitochondrial MnSOD), SOD3 (extracellular Cu/ZnSOD) and CAT in a cohort of preterm infants and correlate their presence to the development of respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), intraventricular haemorrhage (IVH) and retinopathy of prematurity (ROP). We carried out a retrospective study to evaluate the allele frequency and the genotype distribution of polymorphisms of SODs and CAT in a population of preterm neonates (n = 152) with a gestational age ≤ 28 weeks according to the presence or absence of RDS, BPD, IVH and ROP. Moreover, we evaluated through the haplotype reconstruction analysis whether combinations of the selected polymorphisms are related to the occurrence of RDS, BPD, IVH and ROP. We found that rs8192287 SOD3 polymorphism is an independent protective factor for all grade IVH, while rs4880 and rs5746136 SOD2 polymorphisms are associated with a lower gestational age (rs4880, rs5746136) and birth weight (rs4880). Haplotypes reconstruction showed that SOD1 (GG) decreased the risk of RDS, IVH and ROP; SOD2 (GT) increased the risk of BPD and decreased the risk of RDS, IVH and ROP; SOD3 (TGC) decreased the risk of BPD and IVH; and 4) CAT (CTC) decreased the risk of RDS. The rs8192287 SOD3 polymorphism is per se an independent predictor of a decreased risk of developing IVH. Different SOD2 polymorphisms are associated per se with a lower gestational age and/or birth weight, and haplotypes of SOD1, SOD3 and CAT genes may be independent protecting or risk markers for prematurity complications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22574884     DOI: 10.3109/10715762.2012.692787

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  19 in total

Review 1.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 2.  Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).

Authors:  Daniel J Raiten; Fayrouz A Sakr Ashour; A Catharine Ross; Simin N Meydani; Harry D Dawson; Charles B Stephensen; Bernard J Brabin; Parminder S Suchdev; Ben van Ommen
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

Review 3.  Genetic predisposition to bronchopulmonary dysplasia.

Authors:  Charitharth Vivek Lal; Namasivayam Ambalavanan
Journal:  Semin Perinatol       Date:  2015-10-23       Impact factor: 3.300

Review 4.  Genomics in the neonatal nursery: Focus on ROP.

Authors:  Mary Elizabeth Hartnett; C Michael Cotten
Journal:  Semin Perinatol       Date:  2015-10-23       Impact factor: 3.300

Review 5.  Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period.

Authors:  Marta Perez; Mary E Robbins; Cecilie Revhaug; Ola D Saugstad
Journal:  Free Radic Biol Med       Date:  2019-04-05       Impact factor: 7.376

6.  Antioxidant response genes sequence variants and BPD susceptibility in VLBW infants.

Authors:  Venkatesh Sampath; Jeffery S Garland; Daniel Helbling; David Dimmock; Neil P Mulrooney; Pippa M Simpson; Jeffrey C Murray; John M Dagle
Journal:  Pediatr Res       Date:  2014-12-17       Impact factor: 3.756

Review 7.  Progress in understanding the genetics of bronchopulmonary dysplasia.

Authors:  Gary M Shaw; Hugh M O'Brodovich
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

Review 8.  Developmental regulation of antioxidant enzymes and their impact on neonatal lung disease.

Authors:  Sara K Berkelhamer; Kathryn N Farrow
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

Review 9.  The progress of prophylactic treatment in retinopathy of prematurity.

Authors:  Hong-Bing Zhang; Xiao-Dong Wang; Kun Xu; Xiao-Gang Li
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

10.  Genetic variants associated with severe retinopathy of prematurity in extremely low birth weight infants.

Authors:  M Elizabeth Hartnett; Margaux A Morrison; Silvia Smith; Tammy L Yanovitch; Terri L Young; Tarah Colaizy; Allison Momany; John Dagle; Waldemar A Carlo; Erin A S Clark; Grier Page; Jeff Murray; Margaret M DeAngelis; C Michael Cotten
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-12       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.